TrialJournal of neuro-oncology2010
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Andrew D Norden et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
92 papers cite itlatest 60 shown
this paperpooled ittrialcites it